Target intelligence / Profile preview

High mobility group box 3 pseudogene 27 (HMGB3P27)

Target
HMGB3P27
Molecular classification
Pseudogene, High mobility group (HMG) family (by sequence, not function), Other
01

Overview

HMGB3P27 (high mobility group box 3 pseudogene 27) is classified as a pseudogene of the high mobility group (HMG) family. Pseudogenes like HMGB3P27 result from duplication or mutation of functional genes—in this case, HMGB3—which encode DNA-binding proteins involved in chromatin structure and transcriptional regulation. Pseudogenes typically do not produce functional proteins; their transcripts may be non-functional or rarely contribute to regulatory functions, potentially affecting the expression of homologous protein-coding genes through RNA interference or other mechanisms, although no function has been specifically established for HMGB3P27. It is not considered a canonical therapeutic target or biomarker, and no drugs are known to interact with it[4][1][11][13].

Other names
putative high mobility group protein B3-like proteinhigh-mobility group protein B3-like protein-likehigh-mobility group box 3 pseudogene 27
02

Biological functions

OtherPseudogenes can sometimes play regulatory roles through RNA-mediated actions, such as acting as competing endogenous RNAs or scaffolds for RNA binding proteins, but there is no evidence for protein-coding or direct functional roles attributed to HMGB3P27 specifically
03

Disease associations

OtherPseudogenes are sometimes associated with disease via their potential to regulate functional genes, but no specific disease association is documented for HMGB3P27

Beyond the preview

Go deeper on High mobility group box 3 pseudogene 27 (HMGB3P27).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on High mobility group box 3 pseudogene 27 (HMGB3P27).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call